XML 71 R60.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Subsequent Events (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Apr. 19, 2023
May 31, 2024
Apr. 30, 2024
Mar. 31, 2024
Dec. 31, 2023
Subsequent Event [Member] | Deferred Bonus [Member]          
Subsequent Event [Line Items]          
Bonus paid   $ 500,000      
Subsequent Event [Member] | Deferred Bonus [Member] | Thomas Equels [Member]          
Subsequent Event [Line Items]          
Bonus paid   350,000      
Subsequent Event [Member] | Deferred Bonus [Member] | Peter Rodino [Member]          
Subsequent Event [Line Items]          
Bonus paid   $ 150,000      
Subsequent Event [Member] | Series B Convertible Preferred Stock [Member]          
Subsequent Event [Line Items]          
Number of shares expried     689    
Purchase And Registration Rights Agreement [Member] | Subsequent Event [Member]          
Subsequent Event [Line Items]          
Number of shares sold     9,975,000    
Purchase And Registration Rights Agreement [Member] | Subsequent Event [Member] | Atlas Sciences LLC [Member]          
Subsequent Event [Line Items]          
Number of shares sold     9,636,400    
Commitment shares issued     $ 338,600    
Equity Purchase Agreement [Member] | Subsequent Event [Member] | Atlas Sciences LLC [Member]          
Subsequent Event [Line Items]          
Number of shares purchased   206,800      
Equity Distribution Agreement [Member] | Maxim Group LLC [Member]          
Subsequent Event [Line Items]          
Number of shares sold     730,110    
Number of shares purchased       564,568 598,114
Proceeds from issuance of common stock     $ 372,223 $ 253,870 $ 344,000
Transaction fee rate 3.00%   3.00% 3.00% 3.00%
Sale of stock, consideration received     $ 11,167 $ 7,616 $ 10,326
Equity Distribution Agreement [Member] | Subsequent Event [Member] | Maxim Group LLC [Member]          
Subsequent Event [Line Items]          
Number of shares purchased     730,110    
Proceeds from issuance of common stock     $ 372,223    
Transaction fee rate     3.00%    
Sale of stock, consideration received     $ 11,167